SG56484G - 6-b-substituted penicillanic acids as b-lactamase inhibitors - Google Patents

6-b-substituted penicillanic acids as b-lactamase inhibitors

Info

Publication number
SG56484G
SG56484G SG564/84A SG56484A SG56484G SG 56484 G SG56484 G SG 56484G SG 564/84 A SG564/84 A SG 564/84A SG 56484 A SG56484 A SG 56484A SG 56484 G SG56484 G SG 56484G
Authority
SG
Singapore
Prior art keywords
lactamase inhibitors
penicillanic acids
substituted penicillanic
substituted
acids
Prior art date
Application number
SG564/84A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG56484G publication Critical patent/SG56484G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG564/84A 1979-03-05 1984-08-13 6-b-substituted penicillanic acids as b-lactamase inhibitors SG56484G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1780979A 1979-03-05 1979-03-05
US06/096,832 US4397783A (en) 1979-03-05 1979-11-23 Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners

Publications (1)

Publication Number Publication Date
SG56484G true SG56484G (en) 1985-03-08

Family

ID=26690341

Family Applications (1)

Application Number Title Priority Date Filing Date
SG564/84A SG56484G (en) 1979-03-05 1984-08-13 6-b-substituted penicillanic acids as b-lactamase inhibitors

Country Status (29)

Country Link
US (1) US4397783A (ko)
KR (1) KR840000589B1 (ko)
AR (1) AR225758A1 (ko)
AT (1) AT369744B (ko)
AU (1) AU518472B2 (ko)
CA (1) CA1154011A (ko)
CH (1) CH648850A5 (ko)
DD (1) DD149366A5 (ko)
DE (1) DE3008316C2 (ko)
DK (1) DK157136C (ko)
ES (1) ES8103095A1 (ko)
FI (1) FI71739C (ko)
FR (1) FR2450837A1 (ko)
GB (1) GB2047684B (ko)
GR (1) GR67697B (ko)
HK (1) HK66687A (ko)
IE (1) IE51931B1 (ko)
IL (1) IL59514A (ko)
IT (1) IT1130301B (ko)
KE (1) KE3456A (ko)
LU (1) LU82219A1 (ko)
MY (1) MY8500320A (ko)
NL (1) NL8001286A (ko)
NO (1) NO800617L (ko)
OA (1) OA06496A (ko)
PH (2) PH18550A (ko)
PT (1) PT70898A (ko)
SE (1) SE451329B (ko)
SG (1) SG56484G (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
EP1636240A1 (en) * 2003-06-05 2006-03-22 Pfizer Products Inc. Beta-lactamase inhibitor prodrug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (ko) * 1973-04-04 1982-10-22
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
EP0013617B1 (en) * 1979-01-10 1984-07-04 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them

Also Published As

Publication number Publication date
PT70898A (en) 1980-04-01
US4397783A (en) 1983-08-09
CA1154011A (en) 1983-09-20
MY8500320A (en) 1985-12-31
DD149366A5 (de) 1981-07-08
KR830001941A (ko) 1983-05-19
CH648850A5 (de) 1985-04-15
AR225758A1 (es) 1982-04-30
ATA118980A (de) 1982-06-15
DE3008316A1 (de) 1980-09-25
KE3456A (en) 1984-10-12
GB2047684A (en) 1980-12-03
PH17879A (en) 1985-01-14
IL59514A (en) 1984-01-31
DK157136B (da) 1989-11-13
AT369744B (de) 1983-01-25
OA06496A (fr) 1981-07-31
DK157136C (da) 1990-04-16
FI71739C (fi) 1987-02-09
AU5610580A (en) 1980-09-18
IE51931B1 (en) 1987-04-29
GR67697B (ko) 1981-09-07
ES489186A0 (es) 1981-02-16
GB2047684B (en) 1983-09-28
AU518472B2 (en) 1981-10-01
IT1130301B (it) 1986-06-11
LU82219A1 (fr) 1980-09-24
FR2450837A1 (fr) 1980-10-03
FI800662A (fi) 1980-09-06
SE451329B (sv) 1987-09-28
NL8001286A (nl) 1980-09-09
ES8103095A1 (es) 1981-02-16
IL59514A0 (en) 1980-06-30
DE3008316C2 (de) 1982-12-16
NO800617L (no) 1980-09-08
PH18550A (en) 1985-08-09
DK92880A (da) 1980-09-06
FR2450837B1 (ko) 1984-01-13
IE800428L (en) 1980-09-05
HK66687A (en) 1987-09-25
KR840000589B1 (ko) 1984-04-24
FI71739B (fi) 1986-10-31
SE8001689L (sv) 1980-09-06
IT8020368A0 (it) 1980-03-05

Similar Documents

Publication Publication Date Title
PH16219A (en) Derivatives of 6b-hydroxyalkylpenicillanic acids as b-lactamase inhibitors
GB2081269B (en) Penicillanic acid derivatives
GB2044255B (en) Penicillin derivatives
JPS5625146A (en) 33aminopropanesulfonic acid derivative
EG14888A (en) Acetoxymethyl penam compounds as b-lactamase inhibitors
KE3456A (en) 6-b-substituted penicillanic acids as b-lactamase inhibitors
GB2048857B (en) -lactamase inhibitors
JPS5612365A (en) Mercaptoacylamino acid derivative
JPS5677262A (en) Mercaptoacyldihydropyrazolecarboxylic acid derivative
JPS5659742A (en) Nnacyllamino acid derivative
GB2051046B (en) Penicillanic acid derivatives
JPS55149251A (en) Substituted pyrrolidinylbenzoic acid derivative
GB2052981B (en) Penicillanic acid derivatives as -lactamose inhibitors
ZM3080A1 (en) 6-beta-substituted penicillanic acids as beta-lactamase inhibitors
JPS5615269A (en) Dihydronicotinic acid derivative
JPS567747A (en) Acylaminobenzoic acid derivative
ZA80905B (en) Penicillin derivatives
IE791028L (en) Penicillanic acid derivative
JPS5640661A (en) Carboxylic acid derivative
JPS55145647A (en) Alphaahalomethylamino acids
JO1057B1 (en) The 6-beta-substituted penicillic acids are formulated by agents to prevent the formation of the beta-lactamase enzyme
SG55984G (en) Penicillanic acid derivatives
ZA782140B (en) Penicillanic acid 1,1-dioxides as b-lactamase inhibitors
IL64644A (en) Substituted decahydro-oxoquinolinecarboxylic acid esters
IE791724L (en) Mercaptoacylamino acids